The 2025 Translational Microbiome Conference

Arrowhead Sci-Tech Conferences & Events is pleased to announce the return of the Annual Translational Microbiome Conference in the spring of 2025. The Translational Microbiome Conference was the first microbiome conference in the field to focus on the hurdles and challenges to clinical success in the space and continues to expand on that mission yearly, bringing well considered and curated content to a diverse audience at an affordable price.

The Annual Translational Microbiome Conference continues to be an integral venue for industry, academia and government to share microbiome research and connect with colleagues in the field. This meeting showcases ground-breaking research being performed by leadings scientists from around the globe. Attendees will have the opportunity to hear the leading companies and academicians discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.

Cutting-Edge Research: Immerse yourself in the latest breakthroughs, advancements, and scientific insights in microbiome research.

Interdisciplinary Perspectives: Engage in stimulating discussions that bridge the gap between different disciplines, including microbiology, genomics, immunology and bioinformatics.

Networking Opportunities: Connect with a diverse community of researchers, scientists, and industry professionals passionate about the microbiome.

Poster Sessions and Oral Presentations: Showcase your own research findings or gain inspiration from the work of others through interactive poster sessions and oral presentations.

Technology and Methodology Showcase: Explore cutting-edge technologies, innovative methodologies, and analytical tools that are revolutionizing microbiome research.

Translational Applications: Discover how microbiome research is shaping our understanding of human health, disease, and therapeutics. Gain insights into the development of microbiome-based interventions.

• Mapping the microbiome at the molecular level
• Cancer & the microbiome
• Microbial dysbiosis and various disease states
• Type 1 diabetes, obesity & the gut microbiome

• The oral microbiome and its correlation with chronic systemic conditions
• Diet and the microbiome-gut-brain axis
• Synthetic biology-based microbiome therapeutics
• The infant gut microbiome

• Biomarker discovery for microbiome-related diseases
• Clinical metagenomics for precision infectious disease diagnostics
• Bioinformatic tools and AI to support the use of microbial genomic data
• Precision microbiome analysis

• Women's health and the microbiome
• Regulatory guidelines for microbiome based therapeutics
• Standards for microbiome measurements